Clinical Investigation| Volume 359, ISSUE 1, P27-31, January 2020

Download started.


Uric Acid Level as a Predictor of Long-Term Mortality in Advanced Age Population

Published:November 07, 2019DOI:



      Hyperuricemia is associated with the development, progression and outcome of several diseases. The purpose of this study is to evaluate the serum uric acid (UA) levels as a predictor of long-term mortality in an older population (age 60 years and above).

      Materials and Methods

      Patients older than 60 years who were hospitalized in the departments of geriatrics and internal medicine in Shaare Zedek Medical Center in Jerusalem during a period of 4 months (March-June 2014) were included in this observational study. Association between hyperuricemia and long-term mortality were analyzed using multiple logistic regression, Kaplan-Meier and Cox proportional hazards regressions analysis.


      A total of 624 patients were included in our study with mean age of 77.2 ± 14.6 years. Overall, 381 patients died during the follow-up period (61.1%). Mortality rate in the hyperuricemic group (> 7 mg/dL) was higher (69.1%) than in the normouricemic group 58.4%. (P = 0.004). The median survival for hyperuricemic patients was significantly shorter compared to normouricemic patients (606 and 1018 days, respectively, P < 0.0001). High levels of UA were significantly associated with higher long-term mortality in patients with cardiovascular disease at their admission (P < 0.000).


      Elevated levels of UA in older patients in acute settings is a predictor of long-term mortality.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fang J
        • Alderman MH
        Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.
        JAMA. 2000; 283: 2404-2410
        • Niskanen LK
        • Laaksonen DE
        • Nyyssönen K
        • et al.
        Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.
        Arch Intern Med. 2004; 164: 1546-1551
        • Anker SD
        • Doehner W
        • Rauchhaus M
        • et al.
        Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
        Circulation. 2003; 107: 1991-1997
        • Kivity S
        • Kopel E
        • Maor E
        • et al.
        Association of serum uric acid and cardiovascular disease in healthy adults.
        Am J Cardiol. 2013; 111: 1146-1151
        • Johnson RJ
        • Segal MS
        • Srinivas T
        • et al.
        Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?.
        J Am Soc Nephrol. 2005; 16: 1909-1919
        • Mora-Ramírez M
        • Estevez-Garcia IO
        • Irigoyen-Camacho ME
        • et al.
        Hyperuricemia on admission predicts short-term mortality due to myocardial Infarction in a population with high prevalence of cardiovascular risk factors.
        Rev Invest Clin. 2017; 69: 247-253
        • Breuer GS
        • Schwartz Y
        • Freier-Dror Y
        • et al.
        Uric acid level as predictor of mortality in the acute care setting of advanced age population.
        Eur J Intern Med. 2017; 44: 74-76
        • Chonchol M
        • Shlipak MG
        • Katz R
        • et al.
        Relationship of uric acid with progression of kidney disease.
        Am J Kidney Dis. 2007; 50: 239-247
        • Weiner DE
        • Tighiouart H
        • Elsayed EF
        • et al.
        Uric acid and incident kidney disease in the community.
        J Am Soc Nephrol. 2008; 19: 1204-1211
        • Obermayr RP
        • Temml C
        • Gutjahr G
        • et al.
        Elevated uric acid increases the risk for kidney disease.
        J Am Soc Nephrol. 2008; 19: 2407-2413
        • Tscharre M
        • Herman R
        • Rohla M
        • et al.
        Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
        Atherosclerosis. 2018; 270: 173-179
        • Mantovania A
        • Targhera G
        • Temporelli PL
        • et al.
        Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: a post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial.
        Metabolism. 2018; 83: 205-215
        • Coiro S
        • Carluccio E
        • Biagioli P
        • et al.
        Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failure.
        Nutr Metab Cardiovasc Dis. 2018; 28: 361-368
        • Heras M
        • Fernández-Reyes MJ
        • Sánchez R
        • et al.
        Serum uric acid as a marker of all-cause mortality in an elderly patient cohort.
        Nefrologia. 2012; 32: 67-72
        • Juraschek SP
        • Tunstall-Pedoe H
        • Woodward M
        Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.
        Atherosclerosis. 2014; 233: 623-629
        • Wasserman A
        • Shnell M
        • Boursi B
        • et al.
        Prognostic significance of serum uric acid in patients admitted to the department of medicine.
        Am J Med Sci. 2010; 339: 15-21